Can CDK4/6 inhibitors cause fatal lung injury?

被引：36
|
作者：
Jazieh, Khalid A. [1 ]
Budd, G. Thomas [2 ]
Dalpiaz, Nancy [2 ]
Abraham, Jame [2 ]
机构：
[1] Cleveland Clin Fdn, Dept Internal Med, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Taussig Canc Ctr, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2019年 / 19卷 / 11期
关键词：
Breast Cancer; Palbociclib; Abemaciclib; Pneumonitis; Toxicity; PALBOCICLIB; PNEUMONITIS; CANCER; RISK;
D O I：
10.1080/14737140.2019.1674651
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：917 / 919
页数：3
相关论文
共 50 条
  • [1] CDK4/6 inhibitors
    不详
    CHEMICAL & ENGINEERING NEWS, 2016, : 30 - 31
  • [2] CDK4/6 inhibitors prolong OS
    Killock, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (12) : 722 - 722
  • [3] CDK4/6 inhibitors: The Devil is in the Detail
    Magge, Tara
    Rajendran, Sneha
    Brufsky, Adam M.
    Foldi, Julia
    CURRENT ONCOLOGY REPORTS, 2024, 26 (06) : 665 - 678
  • [4] Development and strategies of CDK4/6 inhibitors
    Chen, Pingping
    Xu, Yinqiu
    Li, Xuanyi
    Yao, Hequan
    Lin, Kejiang
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (02) : 127 - 145
  • [5] Immunomodulatory effects of CDK4/6 inhibitors
    Zhang, Shumeng
    Xu, Qiaomai
    Sun, Wenjia
    Zhou, Jianya
    Zhou, Jianying
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (04):
  • [6] CDK4/6 inhibitors prolong OS
    David Killock
    Nature Reviews Clinical Oncology, 2019, 16 : 722 - 722
  • [7] CDK4/6 inhibitors in breast cancer
    Dukelow, Tim
    Kishan, Divya
    Khasraw, Mustafa
    Murphy, Conleth G.
    ANTI-CANCER DRUGS, 2015, 26 (08) : 797 - 806
  • [8] Clinicopathologic Features of Acute Kidney Injury Associated With CDK4/6 Inhibitors
    Gupta, Shruti
    Caza, Tiffany
    Herrmann, Sandra M.
    Sakhiya, Vipulbhai C.
    Jhaveri, Kenar D.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (03): : 618 - 623
  • [9] Pseudo acute kidney injury in patients receiving CDK4/6 inhibitors
    Buijs, Sanne M.
    Jongbloed, Elisabeth M.
    van Bergen, Lotte E. M.
    Ramakers, Christian R. B.
    Koolen, Stijn L. W.
    Mathijssen, Ron H. J.
    Betjes, Michiel G. H.
    Jager, Agnes
    BRITISH JOURNAL OF CANCER, 2025, 132 (06) : 525 - 532
  • [10] CDK4/6 inhibitors in lung cancer: current practice and future directions
    Lv, Shuoshuo
    Yang, Jie
    Lin, Jiayuh
    Huang, Xiaoying
    Zhao, Haiyang
    Zhao, Chengguang
    Yang, Lehe
    EUROPEAN RESPIRATORY REVIEW, 2024, 33 (171):
12345